Stock Events

Stock Events

Noveris Health Sciences 

€0.16
0
+€0+2.46% Friday 07:05

Statistics

Day High
0.16
Day Low
0.16
52W High
-
52W Low
-
Volume
890
Avg. Volume
-
Mkt Cap
195,624
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

27MarExpected
Q2 2025
Next
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-4.26MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0NF1.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Compass Pathways
CMPS
Mkt Cap606.35M
Compass Pathways focuses on psilocybin therapy for mental health disorders, directly competing in the psychedelic medicine space with Mydecine Innovations.
AtaiBeckley
ATAI
Mkt Cap1.56B
ATAI Life Sciences is a biotech company working on mental health treatments using psychedelics, overlapping with Mydecine's focus areas.
Cybin Inc
CYBN
Mkt Cap200.49M
Cybin Inc. is developing psychedelic compounds for therapeutic purposes, competing in the same niche as Mydecine Innovations.
GH Research
GHRS
Mkt Cap888.26M
GH Research focuses on developing 5-MeO-DMT therapies for depression, competing in the psychedelic treatment market.
Revive Therapeutics
RVVTF
Mkt Cap4.68M
Revive Therapeutics is exploring the use of psychedelics for medical treatments, including areas Mydecine Innovations is involved in.
Nuveen Municipal Income
NUMI
Mkt Cap0
Numinus Wellness is engaged in psychedelic production and therapy, directly competing with Mydecine's business model.
TripAdvisor
TRIP
Mkt Cap1.87B
Red Light Holland is involved in the production and sale of recreational truffles, indirectly competing by promoting psychedelic acceptance.

About

Mydecine Innovations Group Inc., a biotechnology company, engages in the development and commercialization of psilocybin products for treating mental health problems. The company primarily focuses on treating smoking cessation. Its lead product drug candidates include MYCO-001, MYCO-002, MYCO003, and MYCO-004. Mydecine Innovations Group Inc. has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. The company was formerly known as NewLeaf Brands Inc. and changed its name to Mydecine Innovations Group Inc. in June 2020. Mydecine Innovations Group Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.
Show more...
CEO
Mr. David Joshua Bartch
Employees
3
Country
CA
ISIN
CA66990B1085
WKN
000A42208

Listings

F
DE
0NF.F
OTC Link
US
MYCOF
CN
CA
NVRS.CN
F
DE
0NF1.F

0 Comments

Share your thoughts

FAQ

What is Noveris Health Sciences stock price today?▼
The current price of 0NF1.F is €0.16 EUR — it has increased by +2.46% in the past 24 hours. Watch Noveris Health Sciences stock price performance more closely on the chart.
What is Noveris Health Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Noveris Health Sciences stocks are traded under the ticker 0NF1.F.
What is Noveris Health Sciences market cap?▼
Today Noveris Health Sciences has the market capitalization of 195,624
When is the next Noveris Health Sciences earnings date?▼
Noveris Health Sciences is going to release the next earnings report on March 27, 2026.
What is Noveris Health Sciences revenue for the last year?▼
Noveris Health Sciences revenue for the last year amounts to 0 EUR.
What is Noveris Health Sciences net income for the last year?▼
0NF1.F net income for the last year is -4.26M EUR.
How many employees does Noveris Health Sciences have?▼
As of February 10, 2026, the company has 3 employees.
In which sector is Noveris Health Sciences located?▼
Noveris Health Sciences operates in the Health Care sector.
When did Noveris Health Sciences complete a stock split?▼
Noveris Health Sciences has not had any recent stock splits.
Where is Noveris Health Sciences headquartered?▼
Noveris Health Sciences is headquartered in Vancouver, CA.